These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [Role of monoclonal antibodies in the treatment of immune-mediated kidney disease: an introduction]. Feriozzi S G Ital Nefrol; 2012; 29(3):267-73; discussion 292. PubMed ID: 22718449 [TBL] [Abstract][Full Text] [Related]
30. [Immunostimulant therapy of kidney diseases]. Karastanev I Vutr Boles; 1982; 21(3):8-13. PubMed ID: 6180558 [No Abstract] [Full Text] [Related]
31. Drug discovery in renal disease--towards a more efficient framework. Miyata T; Ando T; Hiragi H; Watanabe K; Yamamoto F; Vaughan DE; Kurokawa T; Oshima Y; van Ypersele de Strihou C; Takeuchi M Nat Rev Nephrol; 2014 May; 10(5):290-6. PubMed ID: 24642801 [TBL] [Abstract][Full Text] [Related]
32. Immune aspects of renal diseases. Wilson CB JAMA; 1987 Nov; 258(20):2957-61. PubMed ID: 2959799 [No Abstract] [Full Text] [Related]
33. Rituximab treatment in lupus nephritis--where do we stand? Gunnarsson I; Jonsdottir T Lupus; 2013 Apr; 22(4):381-9. PubMed ID: 23553781 [TBL] [Abstract][Full Text] [Related]
34. Lupus nephritis: where are we now? Lightstone L Curr Opin Rheumatol; 2010 May; 22(3):252-6. PubMed ID: 20305561 [TBL] [Abstract][Full Text] [Related]
35. Murine and Human Lupus Nephritis: Pathogenic Mechanisms and Theoretical Strategies for Therapy. Pedersen HL; Horvei KD; Thiyagarajan D; Seredkina N; Rekvig OP Semin Nephrol; 2015 Sep; 35(5):427-38. PubMed ID: 26573545 [TBL] [Abstract][Full Text] [Related]
36. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
37. [Intravenous immunoglobulins in the treatment of glomerulopathies]. Floccari F; Palla R; Polito P; Campo S; Aloisi C; Buemi M G Ital Nefrol; 2007; 24(4):311-9. PubMed ID: 17659502 [TBL] [Abstract][Full Text] [Related]
38. Review of autoimmune (lupus-like) glomerulonephritis in murine models. Hicks J; Bullard DC Ultrastruct Pathol; 2006; 30(5):345-59. PubMed ID: 17090514 [TBL] [Abstract][Full Text] [Related]
39. Integrative continuum: accelerating therapeutic advances in rare autoimmune diseases. Van Herle K; Behne JM; Van Herle A; Blaschke TF; Smith TJ; Yeaman MR Annu Rev Pharmacol Toxicol; 2012; 52():523-47. PubMed ID: 22235861 [TBL] [Abstract][Full Text] [Related]
40. Role of macrophage migration inhibition factor in kidney disease. Lan HY Nephron Exp Nephrol; 2008; 109(3):e79-83. PubMed ID: 18663334 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]